Related Experiment Video
Updated: Jan 14, 2026
07:16
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
14.6K
PACT is requisite for prostate cancer cell proliferation
Dianne J Beveridge1, Andrew J Woo1,2, Kirsty L Richardson1
1Laboratory for Cancer Medicine, Harry Perkins Institute of Medical Research, and Centre for Medical Research, The University of Western Australia, Crawley, WA, 6009, Australia.
Scientific Reports
|October 21, 2025
Summary
PACT protein promotes prostate cancer (PCa) cell proliferation. Depleting PACT reduces PCa cell growth and may offer a new therapeutic strategy for prostate cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Virology
Background:
- PACT (PRKRA gene) is an RNA-binding protein involved in antiviral defense and nuclear receptor gene regulation.
- Previous work identified PACT's role in modulating nuclear receptor-regulated gene expression.
Purpose of the Study:
- To investigate the role of PACT in prostate cancer (PCa) pathogenesis.
- To explore PACT as a potential therapeutic target in PCa.
Main Methods:
- Loss-of-function studies using PACT depletion in PCa cell lines.
- RNA-sequencing analysis to identify PACT-regulated genes and pathways.
- siRNA-mediated knockdown of specific genes and assessment of cell proliferation.
- Analysis of androgen receptor (AR) signaling and PSA gene expression.
Main Results:
- PACT depletion reduced PCa cell proliferation but maintained viability.
- RNA-seq revealed downregulation of cell cycle, mitochondrial function, and NR-response pathways in PACT knockout cells.
- Downregulated genes, including KLK3 (PSA), upon PACT depletion also reduced cell growth.
- PACT or PSA reduction induced G0/G1 cell cycle arrest.
- PACT knockout cells showed altered PSA gene expression in response to hormonal stimuli and AR antagonists.
Conclusions:
- PACT plays a pro-proliferative role in prostate cancer.
- Therapeutic strategies targeting PACT or PACT-downregulated genes (like PSA) show promise for PCa treatment.
Related Concept Videos
02:23Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
01:23Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:19Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K